Basit öğe kaydını göster

dc.contributor.authorAkkiz, Hikmet
dc.contributor.authorCarr, Brian I.
dc.contributor.authorYalcin, Kendal K.
dc.contributor.authorGuerra, Vito
dc.contributor.authorKuran, Sedef
dc.contributor.authorAltintas, Engin
dc.contributor.authorUskudar, Oguz
dc.contributor.authorKaraogullarindan, Umit
dc.contributor.authorOzakyol, Aysegul
dc.contributor.authorTokmak, Salih
dc.contributor.authorYucesoy, Mehmet
dc.contributor.authorBahceci, Halil Ibrahim
dc.contributor.authorUlku, Abdulalh
dc.contributor.authorAkcam, Tolga
dc.contributor.authorPolat, Kamil Yalcin
dc.contributor.authorEkinci, Nazim
dc.contributor.authorSimsek, Halis
dc.contributor.authorOrmeci, Necati
dc.contributor.authorSonsuz, Abdulalh
dc.contributor.authorDemir, Mehmet
dc.contributor.authorKilic, Murat
dc.contributor.authorUygun, Ahmet
dc.contributor.authorBalli, Tugsan
dc.contributor.authorDemir, Ali
dc.contributor.authorArslan, Burcu
dc.contributor.authorDoran, Figen
dc.date.accessioned2019-12-10T11:10:45Z
dc.date.available2019-12-10T11:10:45Z
dc.date.issued2018
dc.identifier.issn0030-2414
dc.identifier.urihttps://doi.org/10.1159/000484564
dc.identifier.urihttp://hdl.handle.net/11655/14907
dc.description.abstractA large cohort of hepatocellular carcinoma (HCC) patients from several collaborating Turkish institutions were examined for the tumor parameters of maximum diameter (MTD), portal vein thrombosis (PVT), and alpha-fetoprotein (AFP) levels. A relationship was found between MTD and blood platelet levels. Patients with large >= 5 cm tumors who had normal platelet levels had significantly larger tumors, higher percent of PVT, and significantly lower blood total bilirubin and liver cirrhosis than similar >= 5 cm tumor patients having thrombocytopenia. A comparison of patients with and without PVT showed significantly larger tumors, greater multifocality, blood AFP, and C-reactive protein levels, and, interestingly, lower HDL levels in the patients with PVT. Fifty-eight percent of the total cohort had AFP levels <= 100 IU/mL ( and 42.1% had values <= 20 IU/mL). These patients had significantly smaller tumors, less tumor multifocality and percent PVT, lower total bilirubin, and less cirrhosis. There was considerable geographic heterogeneity within Turkey in the patterns of HCC presentation, with areas of higher and lower hepatitis B virus, hepatitis D virus, cirrhosis, and tumor aggressiveness parameters. Turkish patients thus have distinct patterns of presentation, but the biological relationships between MTD and both platelets and bilirubin levels are similar to the relationships that have been reported in other ethnic patient groups. (C) 2017 S. Karger AG, Basel
dc.language.isoen
dc.publisherKarger
dc.relation.isversionof10.1159/000484564
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectOncology
dc.titleCharacteristics Of Hepatocellular Carcinoma Aggressiveness Factors In Turkish Patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalOncology
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume94
dc.identifier.issue2
dc.identifier.startpage116
dc.identifier.endpage124
dc.description.indexWoS


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster